Affluent Medical

Affluent Medical, headquartered in Paris, was founded two years ago by the investment fund Truffle Capital SAS. It was formed through the merger of four French startups: Kephalios SAS, Kardiozis SAS, Epygon SAS, and Myopowers SAS. These four companies, part of Truffle Capital's portfolio, are partners dedicated to developing a new generation of minimally invasive technologies based on fluid control for the treatment of aneurysms, severe mitral regurgitation, and severe urinary incontinence.